<http://webisa.webdatacommons.org/226196971>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<sec.gov> .
<http://webisa.webdatacommons.org/prov/462719976>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/226196971> .
<http://webisa.webdatacommons.org/226196971>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/226196971>	<http://www.w3.org/ns/prov#value>	"Risks Related to our Business, including the Development, Regulatory Approval and Potential Commercialization of our Product Candidate, EVK-001 Our business is entirely dependent on the success of a single product candidate, EVK-001, which has not yet entered a Phase 3 clinical trial." .